Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/05/2012 | CN102274237B Novel application of flavonoid compound |
12/05/2012 | CN102274202B Daidzein nanocrystal immediate-release capsule and preparation process thereof |
12/05/2012 | CN102274190B Paclitaxel alhumin submicron for injection and preparation method thereof |
12/05/2012 | CN102258758B High-content liquid gingerols and preparation method thereof |
12/05/2012 | CN102258535B Method for preparing veterinary compound iron dextran injection and influence of veterinary compound iron dextran injection on growth of mice |
12/05/2012 | CN102210672B Application of polyketide in preparation of angiogenesis inhibiting medicine |
12/05/2012 | CN102198105B Nafcillin sodium injection and preparation method thereof |
12/05/2012 | CN102198080B Adriamycin sustained-release medicinal rod for treating Cerebral gliomas disease and preparation method thereof |
12/05/2012 | CN102191244B Group of siRNA molecules capable of effectively reducing PRDM1beta expression and application thereof |
12/05/2012 | CN102188395B Stable meropenem injection and preparation method thereof |
12/05/2012 | CN102178685B Application of taurochenodeoxycholic acid in protection of adrenal gland function |
12/05/2012 | CN102178661B Levo-tetrahydropalmatine transdermal drug delivery preparation |
12/05/2012 | CN102151260B Andrographolide and berberine combination and application thereof |
12/05/2012 | CN102149682B Preparation methods and uses of 1-(substituted aryl)-5-trifluoromethyl-2-(1H)-pyridone compounds and their salts |
12/05/2012 | CN102149380B A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivatives or their salts, and alendronic acid or its salt |
12/05/2012 | CN102145002B Use of rupatadine for preventing or treating pulmonary fibrosis |
12/05/2012 | CN102106851B Application of brusatol as chemotherapeutic drug synergist |
12/05/2012 | CN102086193B N-substituted alpha-amino acid derivatives and preparation method and application thereof |
12/05/2012 | CN102070532B Anti-tumor medicament structure |
12/05/2012 | CN102056609B Pharmaceutical combination |
12/05/2012 | CN102030807B Theasapogenol derivative with anti-HIV (Human Immunodeficiency Virus) activity, preparation method and application thereof |
12/05/2012 | CN102028939B Medicine with hirudin-containing active ingredient |
12/05/2012 | CN102028938B Medicament having effects of activating blood and dissolving stasis |
12/05/2012 | CN102018686B Mitomycin-containing film agent and preparation method thereof |
12/05/2012 | CN101991561B 3,4-dichlorophenyl-propenoyl-sec-butylamine composition |
12/05/2012 | CN101966173B Medicinal use of dinitrobenzoylsilybin for preparing glycosidase inhibitor |
12/05/2012 | CN101953506B Beta-glucan-tea polyphenol compound and application thereof |
12/05/2012 | CN101951899B Abnormal intraocular pressure treatment |
12/05/2012 | CN101951898B Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate |
12/05/2012 | CN101928213B Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom |
12/05/2012 | CN101919840B Application of B/E ring substituted silybin for preparing medicament for treating virus hepatitis B |
12/05/2012 | CN101889010B Isoxazolo-pyridine derivatives |
12/05/2012 | CN101863901B 2-(substituted phenyl)-2-(4,5,6,7-thiophane[3,2-c] pyridine-5(4H)-group)-N-substitute-acetamide as well as preparation method and application thereof |
12/05/2012 | CN101835473B Novel ophthalmic compositions containing latanoprost |
12/05/2012 | CN101810186B Multifunctional disinfectant and preparation method thereof |
12/05/2012 | CN101808639B Antifungal pharmaceutical composition |
12/05/2012 | CN101785799B Extract of total triterpenes in dracocephalum moldavica and preparation method and application thereof |
12/05/2012 | CN101785767B Application of dehydrogenated silibinin diether in preparation of medicaments for preventing and treating leukemia |
12/05/2012 | CN101784285B Composition for ophthalmic disease associated with hypoxia or ischemia |
12/05/2012 | CN101780058B Quick liquid absorption soluble contraceptive membranes |
12/05/2012 | CN101756988B Compound matrine and diversine nano-emulsion preparation and preparation method thereof |
12/05/2012 | CN101732391B Method for enriching and purifying cardiac glycoside of wormseed mustard herb |
12/05/2012 | CN101732268B Montelukast sodium tablet and preparation method thereof |
12/05/2012 | CN101732243B Stable methyl naltrexone injection and preparation method thereof |
12/05/2012 | CN101720321B Steroids derivatives as selective progesterone receptor modulators |
12/05/2012 | CN101711779B Application of Selaginella pulvinata (Hook.et Grev.) Maxim. extract in preparing medicaments for resisting Alzheimer diseases |
12/05/2012 | CN101686996B New application of sulphated xylans for treatment or prophylaxis of respiratory diseases |
12/05/2012 | CN101677952B Improved depot formulations |
12/05/2012 | CN101665489B Dehydrosilybin trialky ether and preparation method and medical application thereof |
12/05/2012 | CN101654427B Anticoagulant compound, composition and application thereof |
12/05/2012 | CN101653437B Novel application of sulfonic benzo-gamma-pyrone compound |
12/05/2012 | CN101641090B Use of modafinil to treat restless leg syndrome |
12/05/2012 | CN101623282B Aspirin-dipyridomole sustained-release capsule and preparation method thereof |
12/05/2012 | CN101618036B Novel medicinal application of carboxyl aminotriazole and acceptable salts of the carboxyl aminotriazole |
12/05/2012 | CN101613346B Preparation method of silibinin ether substituted by A ring and medical application thereof |
12/05/2012 | CN101602733B Diaryl pyridine derivatives, preparation method thereof and application thereof |
12/05/2012 | CN101591344B Antithrombotic compound as well as preparation method and application thereof |
12/05/2012 | CN101590229B Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
12/05/2012 | CN101590095B Compound medicine containing gypenosides and folic acid compound |
12/05/2012 | CN101590084B Pharmaceutical composition containing angiotensin converting enzyme inhibitors, B vitamins and ginkgo biloba extracts |
12/05/2012 | CN101565419B 7 and 20 dehydro-silybin dialky ether and preparation method and medicine use thereof |
12/05/2012 | CN101565404B Heterocyclic compounds |
12/05/2012 | CN101563079B Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
12/05/2012 | CN101559059B Pharmaceutical composition containing amiloride hydrochloride and preparation method thereof |
12/05/2012 | CN101553235B Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
12/05/2012 | CN101541780B Fibrate carboxylate compounds, preparation methods and uses thereof |
12/05/2012 | CN101535258B Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
12/05/2012 | CN101516858B Crystalline antifungal compounds |
12/05/2012 | CN101505752B Prolyl hydroxylase inhibitors |
12/05/2012 | CN101490073B New 5-thioxylopyranose derivatives |
12/05/2012 | CN101444499B Compound and new usage of composition thereof |
12/05/2012 | CN101437510B A pharmaceutical composition useful as acetyl cholinesterase inhibitors |
12/05/2012 | CN101426481B Use of opioid receptor antagonists |
12/05/2012 | CN101415424B Combinations comprising BCR-ABL/C-KIT/PDGF-R TK inhibitors for treating cancer |
12/05/2012 | CN101415409B Combinations of therapeutic agents for treating cancer |
12/05/2012 | CN101410378B Malonamide derivatives as gamma secretase inhibitors |
12/05/2012 | CN101397294B N-substituted pyrrolidine derivates and uses thereof |
12/05/2012 | CN101379055B Substituted quinolones III |
12/05/2012 | CN101370486B Transdermal patch containing Isosorbide Dinitrate and bisoprolol |
12/05/2012 | CN101367869B Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
12/05/2012 | CN101356156B Aspartic protease inhibitors |
12/05/2012 | CN101330919B Pharmaceutical composition including (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrim idin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid |
12/05/2012 | CN101287507B Methods and devices for lymphatic targeting |
12/05/2012 | CN101277740B Antituberculous composition comprising oxazole compounds |
12/05/2012 | CN101263146B 8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents |
12/05/2012 | CN101255131B Heterocyclic derivatives as opioid modulators |
12/05/2012 | CN101232807B Compositions having a high antiviral and antibacterial efficacy |
12/05/2012 | CN101214230B Asepsis patch for relieving postoperative wound pain |
12/05/2012 | CN101184749B Spirocyclic heterocyclic derivatives and methods of their use |
12/05/2012 | CN101087619B Method of treatment or prophylaxis |
12/05/2012 | CN101084204B Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) |
12/05/2012 | CN101068536B Dosage regimen of an S1P receptor agonist |
12/05/2012 | CN101045725B Malate and multicrystal object of some quinolone compound |
12/04/2012 | US8324425 Method for producing bicyclic γ-amino acid derivative |
12/04/2012 | US8324401 Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
12/04/2012 | US8324397 Desferrithiocin polyether analogues |
12/04/2012 | US8324396 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
12/04/2012 | US8324395 Heterocyclic compound and use thereof |
12/04/2012 | US8324394 Substituted acetophenones useful as PDE4 inhibitors |
12/04/2012 | US8324392 Solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one |